- Home
- SYBX vs MDRR Comparison
SYBX vs MDRR Comparison
Compare SYBX & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- MDRR
- Stock Information
- Founded
- SYBX N/A
- MDRR 2015
- Country
- SYBX United States
- MDRR United States
- Employees
- SYBX N/A
- MDRR N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- MDRR Real Estate Investment Trusts
- Sector
- SYBX Health Care
- MDRR Real Estate
- Exchange
- SYBX Nasdaq
- MDRR Nasdaq
- Market Cap
- SYBX 13.9M
- MDRR 15.6M
- IPO Year
- SYBX N/A
- MDRR 2018
- Fundamental
- Price
- SYBX $1.48
- MDRR $11.30
- Analyst Decision
- SYBX
- MDRR
- Analyst Count
- SYBX 0
- MDRR 0
- Target Price
- SYBX N/A
- MDRR N/A
- AVG Volume (30 Days)
- SYBX 96.1K
- MDRR 640.0
- Earning Date
- SYBX 08-15-2025
- MDRR 08-12-2025
- Dividend Yield
- SYBX N/A
- MDRR 2.39%
- EPS Growth
- SYBX N/A
- MDRR N/A
- EPS
- SYBX 0.21
- MDRR N/A
- Revenue
- SYBX N/A
- MDRR $9,485,128.00
- Revenue This Year
- SYBX N/A
- MDRR N/A
- Revenue Next Year
- SYBX N/A
- MDRR N/A
- P/E Ratio
- SYBX $7.06
- MDRR N/A
- Revenue Growth
- SYBX N/A
- MDRR N/A
- 52 Week Low
- SYBX $0.90
- MDRR $9.55
- 52 Week High
- SYBX $1.96
- MDRR $15.00
- Technical
- Relative Strength Index (RSI)
- SYBX 52.72
- MDRR 53.75
- Support Level
- SYBX $1.53
- MDRR $10.45
- Resistance Level
- SYBX $1.96
- MDRR $11.34
- Average True Range (ATR)
- SYBX 0.19
- MDRR 0.12
- MACD
- SYBX -0.01
- MDRR 0.06
- Stochastic Oscillator
- SYBX 36.84
- MDRR 86.87
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.